The Combination Of Keytruda Plus Lenvima Improves Survival In Advanced Endometrial Cancer

Written By Carra Buttress

There was a statistically significant and clinically meaningful improvement in overall survival, progression free survival, and objective response rate compared to chemotherapy in the phase 3 KEYNOTE-775/Study 309 Trial.

Learn More:
https://www.targetedonc.com/view/pembrolizumab-plus-lenvatinib-significant-improve-survival-in-advanced-endometrial-cancer

Back
Carra Buttress
Previous

CAPP2 Study Suggests People With Lynch Syndrome Should Take Aspirin To Reduce Colorectal Cancer Risk
Next

What Is Immunotherapy And How Does It Work Against Cancer?